Baseline Characteristics of the TOPaZ Study: Randomised Trial of Teriparatide and Zoledronic Acid Compared with Standard Care in Adults with Osteogenesis Imperfecta.
Hald JD, Weir C, Keerie C, Dewar L, MacLean M, Milne L, Keen R, Walsh J, Poole K, Langdahl B, Lindsay JR, Ghouri N, Hollick RJ, Aspray T, Crowley RK, Cohen-Solal M, Hassan-Smith Z, Tuck S, Curtis E, Harvey N, Eekhoff EMW, Feenstra J, Hampson G, Stone M, Turton J, Patel P, Siddiqi M, Munro R, Roy M, Paskins Z, Narayanan D, Malcolm E, Javaid MK, Osborne P, Tang JCY, Lam W, Moore D, Black HA, Duckworth AD, Makaram N, Guo T, Stenhouse G, Ralston SH.
Hald JD, et al. Among authors: tang jcy.
Calcif Tissue Int. 2025 Nov 8;116(1):136. doi: 10.1007/s00223-025-01440-3.
Calcif Tissue Int. 2025.
PMID: 41206390
Free PMC article.
Clinical Trial.